Importer of Controlled Substances Registration, 5477 [2019-02871]
Download as PDF
<![CDATA[
5477
Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices
innovative healthcare products. These
comments are consistent with the
United States’ previous recognition that
this merger has the potential to generate
benefits by improving the quality and
lowering the costs of healthcare
services.80
VI. Conclusion
After careful consideration of the
public comments, the United States
continues to believe that the proposed
Final Judgment, as drafted, provides an
effective and appropriate remedy for the
antitrust violations alleged in the
Complaint, and is therefore in the
public interest. The United States will
move this Court to enter the proposed
Final Judgment after the comments and
this response are published as required
by 15 U.S.C. § 16(d).
amozie on DSK3GDR082PROD with NOTICES1
Dated: February 13, 2019
Respectfully submitted,
Jay D. Owen,
Shobitha Bhat,
Natalie R. Melada,
U.S. Department of Justice,
Antitrust Division,
450 Fifth Street NW, Suite 4100,
Washington, D.C. 20530,
Tel.: (202) 598-2987,
Fax: (202) 616-2441,
E-mail: Jay.Owen@usdoj.gov.
Registrants listed below has
applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I or schedule II controlled
substances.
SUMMARY:
The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on the previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–02846 Filed 2–20–19; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Company
FR docket
Mylan Technologies, Inc. .............................................................................................................................
Noramco Inc. ................................................................................................................................................
Arizona Department of Corrections ..............................................................................................................
83 FR 64160
83 FR 64159
83 FR 64364
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or schedule II controlled
substances to the above listed
companies.
DEPARTMENT OF JUSTICE
Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–02871 Filed 2–20–19; 8:45 am]
BILLING CODE 4410–09–P
80 See ‘‘Justice Department Requires CVS and
Aetna to Divest Aetna’s Medicare Individual Part D
VerDate Sep<11>2014
17:08 Feb 20, 2019
Jkt 247001
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 25, 2019. Such persons
may also file a written request for a
hearing on the application on or before
March 25, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
Published
December 13, 2018.
December 13, 2018.
December 14, 2018.
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on October
12, 2018, Johnson Matthey Inc., 2003
Nolte Drive, West Deptford, New Jersey
08066, applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances listed in
schedule I & II.
Controlled substance
Drug
code
Schedule
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
Gamma Hydroxybutyric Acid.
Marihuana .................
Tetrahydrocannabinols.
Dihydromorphine ......
Difenoxin ...................
Amphetamine ...........
Methamphetamine ....
Lisdexamfetamine ....
Methylphenidate .......
Nabilone ...................
Prescription Drug Plan Business to Proceed with
Merger,’’ available at https://www.justice.gov/opa/
pr/justice-department-requires-cvs-and-aetnadivest-aetna-s-medicare-individual-part-d.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\21FEN1.SGM
21FEN1
2010
I
7360
7370
I
I
9145
9168
1100
1105
1205
1724
7379
I
I
II
II
II
II
II
]]>Agencies
[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02871]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below has applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I or schedule II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on the previously published notices is listed
in the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR docket Published
----------------------------------------------------------------------------------------------------------------
Mylan Technologies, Inc.................. 83 FR 64160 December 13, 2018.
Noramco Inc.............................. 83 FR 64159 December 13, 2018.
Arizona Department of Corrections........ 83 FR 64364 December 14, 2018.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or schedule II controlled substances to the
above listed companies.
Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02871 Filed 2-20-19; 8:45 am]
BILLING CODE 4410-09-P
